Bioadhesive Food Protein Nanoparticles as Pediatric Oral Drug Delivery System
Source abstract
Abstract
The goal of this study was to develop bioadhesive food protein nanoparticles using zein (Z), a hydrophobic corn protein, as the core and whey protein (WP) as the shell for oral pediatric drug delivery applications. Lopinavir (LPV), an antiretroviral drug, and fenretinide, an investigational anticancer agent, were used as model drugs in the study. The particle size of ZWP nanoparticles was in the range of 200-250 nm, and the drug encapsulation efficiency was >70%. The nanoparticles showed sustained drug release in simulated gastrointestinal fluids. ZWP nanoparticles enhanced the permeability of LPV and fenretinide across Caco-2 cell monolayers. In both ex vivo and in vivo studies, ZWP nanoparticles were found to be strongly bioadhesive. ZWP nanoparticles enhanced the oral bioavailability of LPV and fenretinide by 4 and 7-fold, respectively. ZWP nanoparticles also significantly increased the half-life of both drugs. The nanoparticles did not show any immunogenicity in mice. Overall, the study demonstrates the feasibility of developing safe and effective food protein-based nanoparticles for pediatric oral drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Proteins in Food Systems · Advanced Drug Delivery Systems · Child Nutrition and Feeding Issues
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of South Dakota, Vermillion, South Dakota 57069, United States
Funding
South Dakota Board of Regents · Department of Pharmaceutical Sciences, South Dakota State University
References (64)
Show source-provided references
1. 10.1542/peds.2013-322510.1542/peds.2013-3225 ↗
2. 10.1111/j.1365-2125.2005.02410.x10.1111/j.1365-2125.2005.02410.x ↗
3. Giacoia G. P. · Int. J. Pharm. Compd. · 2007 · 11 · 220
4. 10.1016/j.phrs.2011.01.00610.1016/j.phrs.2011.01.006 ↗
5. 10.1016/j.addr.2013.10.00610.1016/j.addr.2013.10.006 ↗
6. 10.1016/j.ijpharm.2012.05.02410.1016/j.ijpharm.2012.05.024 ↗
7. 10.1208/s12249-016-0584-110.1208/s12249-016-0584-1 ↗
8. 10.1208/s12248-013-9511-510.1208/s12248-013-9511-5 ↗
9. World Health Organization: better medicines for children: pharmaceutical formulations WHO Drug information 2012, 26. http://www.who.int/medicines/publications/druginformation/issues/26-1.pdf.
10. 10.1016/j.addr.2014.05.00410.1016/j.addr.2014.05.004 ↗
11. 10.1016/S0926-6690(00)00064-910.1016/S0926-6690(00)00064-9 ↗
12. 10.3390/ijms15122243810.3390/ijms151222438 ↗
13. 10.1080/17425247.2017.134975210.1080/17425247.2017.1349752 ↗
14. 10.1016/j.ijpharm.2016.09.02310.1016/j.ijpharm.2016.09.023 ↗
15. 10.1208/s12249-012-9816-110.1208/s12249-012-9816-1 ↗
16. 10.1021/jf102959b10.1021/jf102959b ↗
17. 10.1016/j.foodres.2014.07.00410.1016/j.foodres.2014.07.004 ↗
18. 10.1021/acs.jafc.5b0269910.1021/acs.jafc.5b02699 ↗
19. 10.1021/acs.molpharmaceut.6b0101710.1021/acs.molpharmaceut.6b01017 ↗
20. 10.1021/mp200645510.1021/mp2006455 ↗
21. 10.1016/S1043-4526(08)60130-810.1016/S1043-4526(08)60130-8 ↗
22. 10.1016/j.ijpharm.2018.04.06110.1016/j.ijpharm.2018.04.061 ↗
23. 10.1016/j.foodchem.2013.08.01810.1016/j.foodchem.2013.08.018 ↗
24. 10.1016/j.colsurfb.2015.10.01610.1016/j.colsurfb.2015.10.016 ↗
25. 10.1016/j.ejps.2012.04.00210.1016/j.ejps.2012.04.002 ↗
26. 10.1023/B:PHAM.0000041457.64638.8d10.1023/B:PHAM.0000041457.64638.8d ↗
27. 10.1016/j.ijpharm.2012.05.01410.1016/j.ijpharm.2012.05.014 ↗
28. 10.1097/SMJ.0b013e31819ba21210.1097/SMJ.0b013e31819ba212 ↗
29. 10.1097/QAI.000000000000013510.1097/QAI.0000000000000135 ↗
30. 10.1111/j.1365-2710.2008.00930.x10.1111/j.1365-2710.2008.00930.x ↗
31. 10.1177/153537021770695210.1177/1535370217706952 ↗
32. 10.1158/1078-0432.CCR-11-099510.1158/1078-0432.CCR-11-0995 ↗
33. 10.3797/scipharm.1107-2410.3797/scipharm.1107-24 ↗
34. 10.1016/j.jconrel.2013.05.04310.1016/j.jconrel.2013.05.043 ↗
35. 10.1016/j.foodhyd.2009.06.01510.1016/j.foodhyd.2009.06.015 ↗
36. 10.1016/j.foodchem.2012.04.14610.1016/j.foodchem.2012.04.146 ↗
37. 10.1016/j.ijpharm.2012.11.03310.1016/j.ijpharm.2012.11.033 ↗
38. 10.1016/j.bbapap.2006.04.00210.1016/j.bbapap.2006.04.002 ↗
39. 10.1016/j.idairyj.2011.10.00610.1016/j.idairyj.2011.10.006 ↗
40. 10.1016/j.jconrel.2016.06.01710.1016/j.jconrel.2016.06.017 ↗
41. 10.1208/s12249-014-0151-610.1208/s12249-014-0151-6 ↗
42. 10.1080/0363904090278306610.1080/03639040902783066 ↗
43. 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
44. 10.3390/children202024410.3390/children2020244 ↗
45. 10.1124/dmd.112.04467710.1124/dmd.112.044677 ↗
46. 10.1007/s10637-006-9026-310.1007/s10637-006-9026-3 ↗
47. 10.1023/A:101642830436610.1023/A:1016428304366 ↗
48. 10.1016/j.biomaterials.2013.04.05310.1016/j.biomaterials.2013.04.053 ↗
49. 10.1021/mp500439c10.1021/mp500439c ↗
50. 10.1002/jcp.2265010.1002/jcp.22650 ↗
51. 10.1016/j.bbamem.2007.10.01010.1016/j.bbamem.2007.10.010 ↗
52. 10.1016/j.addr.2005.07.00110.1016/j.addr.2005.07.001 ↗
53. Alexander A. · Int. J. Appl. Biol. Pharm. Technol. · 2011 · 2 · 434
54. 10.1039/c0sm00800a10.1039/c0sm00800a ↗
55. 10.1038/mi.2012.410.1038/mi.2012.4 ↗
56. 10.1021/jf020599h10.1021/jf020599h ↗
57. 10.1002/jsfa.604110.1002/jsfa.6041 ↗
58. 10.1097/INF.000000000000131910.1097/INF.0000000000001319 ↗
59. 10.1016/j.colsurfb.2016.02.01210.1016/j.colsurfb.2016.02.012 ↗
60. 10.3109/03639045.2013.85071010.3109/03639045.2013.850710 ↗
61. 10.3109/10717544.2016.114126010.3109/10717544.2016.1141260 ↗
62. Garaventa A. · Clin. Cancer Res. · 2003 · 6 · 2032
63. 10.1158/1078-0432.CCR-06-188910.1158/1078-0432.CCR-06-1889 ↗
64. Formelli F. · Cancer Chemother. Pharmacol. · 2008 · 62 · 65510.1007/s00280-007-0649-7 ↗